title: Combined radiation and chemotherapy for unresectable non-small cell lung carcinoma.
authors.forename: N M
authors.initials: NM
authors.lastname: Bleehen
authors.forename: D
authors.initials: D
authors.lastname: Ball
authors.forename: C P
authors.initials: CP
authors.lastname: Belani
authors.forename: J
authors.initials: J
authors.lastname: Bishop
authors.forename: J Y
authors.initials: JY
authors.lastname: Douillard
authors.forename: J D
authors.initials: JD
authors.lastname: Cox
authors.forename: D H
authors.initials: DH
authors.lastname: Johnson
authors.forename: T
authors.initials: T
authors.lastname: Le Chevalier
authors.forename: M I
authors.initials: MI
authors.lastname: Saunders
authors.forename: E
authors.initials: E
authors.lastname: Shaw
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy / Q000628:therapy*; D017322:Clinical Trials, Phase II as Topic / Q000379:methods / Q000592:standards*; D017326:Clinical Trials, Phase III as Topic / Q000379:methods / Q000592:standards*; D003131:Combined Modality Therapy; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy / Q000628:therapy*; D009367:Neoplasm Staging; D011878:Radiotherapy / Q000009:adverse effects; D016019:Survival Analysis; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents